Kyndryl Holdings, Inc. <KD.N>: BMO raises target price to $16 from $14
KD•Related News
Lexicon Pharmaceuticals Q2 EPS USD -0.07
LXRX•
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
LGND•
Tecnoglass Q2 revenue and profit beat estimates on strong demand
TGLS•
GH Research says H1 loss widens as R&D spending rises on GH001 clinical, technical development work
GHRS•
Versant Media Q2 revenue falls 3.8%
VSNT•